SUPN financials
Supernus Pharmaceuticals (SUPN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- SUPN revenue was $1.24B in fiscal 2025, net income $210.00M.
SUPN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.24B | $994.00M | $262.00M | $210.00M | 1.64 |
| 2024 | $1.19B | $957.00M | $38.00M | $7.00M | 0.05 |
| 2023 | $1.09B | $919.00M | -$152.00M | -$126.00M | -0.92 |
| 2022 | $901.00M | $749.00M | -$81.00M | -$44.00M | -0.32 |